Low prevalence of archived integrase strand transfer inhibitors resistance associated mutations in Botswana before the roll out of dolutegravir based first line antiretroviral therapy

BackgroundWe evaluated the prevalence of archived proviral drug resistance mutations (DRMs) associated with resistance to integrase strand transfer inhibitors (INSTIs) shortly before Botswana transitioned in 2016 to using dolutegravir (DTG)-based antiretroviral treatment in first-line regimens.Metho...

Повний опис

Бібліографічні деталі

Автори:	Dorcas Maruapula, Doreen Ditshwanelo, Marea N. Pema, Ontlametse T. Bareng, Wonderful T. Choga, Natasha O. Moraka, Patrick T. Mokgethi, Kaelo K. Seatla, Catherine K. Koofhethile, Boitumelo J. Zuze, Tendani Gaolathe, Molly Pretorius-Holme, Kebaneilwe Lebani, Joseph Makhema, Vlad Novitsky, Roger Shapiro, Shahin Lockman, Sikhulile Moyo, Simani Gaseitsiwe
Формат:	Artigo
Мова:	Inglês
Опубліковано:	Frontiers Media S.A. 2024-10-01
Серія:	Frontiers in Microbiology
Предмети:	Botswana HIV integrase strand transfer inhibitor HIV drug resistance mutations antiretroviral therapy
Онлайн доступ:	https://www.frontiersin.org/articles/10.3389/fmicb.2024.1482348/full
Теги:	Додати тег Немає тегів, Будьте першим, хто поставить тег для цього запису!